Type 2 diabetes in melanoma patients: a potential prognostic risk factor?

Br J Dermatol. 2026 May 7:ljag173. doi: 10.1093/bjd/ljag173. Online ahead of print.

Authors

Michelle Marjanovic^{1

2}, Magdalena Claeson^{1

2}

Affiliations

¹ Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
² Department of Dermatology and Venereology, Sahlgrenska University Hospital, Gothenburg, Region Västra Götaland, Sweden.

PMID: 42095268
DOI: 10.1093/bjd/ljag173

No abstract available

Publication types

Editorial
Comment